Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010
Neil Parkin, James Bremer, Silvia Bertagnolio
Antiviral Chemistry & Chemotherapy
|
December 1, 2007
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine
Katyna Borroto-Esoda, Neil Parkin, Michael D Miller
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors
Richard J Colonno, Alexandra Thiry, Kay Limoli, et al.
PLOS Global Public Health
|
October 18, 2023
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries
Neil Parkin, P Richard Harrigan, Seth Inzaule, et al.
Journal of Virology
|
August 7, 2002
Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly
Wolfgang Resch, Rainer Ziermann, Neil Parkin, et al.
Journal of Virology
|
July 30, 2005
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir
Wolfgang Resch, Neil Parkin, Terri Watkins, et al.
The Journal of Infectious Diseases
|
May 4, 2004
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens
Richard Colonno, Ronald Rose, Colin McLaren, et al.
Reviews in Medical Virology
|
August 5, 2025
Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV
Jeffrey V Lazarus, Neil Parkin, Huma Qureshi, et al.
Antiviral Research
|
October 3, 2022
Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir
Soo-Yon Rhee, Neil Parkin, P Richard Harrigan, et al.
Journal of Virus Eradication
|
September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
Joseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010
Neil Parkin, James Bremer, Silvia Bertagnolio
Antiviral Chemistry & Chemotherapy
|
December 1, 2007
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine
Katyna Borroto-Esoda, Neil Parkin, Michael D Miller
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors
Richard J Colonno, Alexandra Thiry, Kay Limoli, et al.
PLOS Global Public Health
|
October 18, 2023
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries
Neil Parkin, P Richard Harrigan, Seth Inzaule, et al.
Journal of Virology
|
August 7, 2002
Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly
Wolfgang Resch, Rainer Ziermann, Neil Parkin, et al.
Journal of Virology
|
July 30, 2005
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir
Wolfgang Resch, Neil Parkin, Terri Watkins, et al.
The Journal of Infectious Diseases
|
May 4, 2004
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens
Richard Colonno, Ronald Rose, Colin McLaren, et al.
Reviews in Medical Virology
|
August 5, 2025
Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV
Jeffrey V Lazarus, Neil Parkin, Huma Qureshi, et al.
Antiviral Research
|
October 3, 2022
Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir
Soo-Yon Rhee, Neil Parkin, P Richard Harrigan, et al.
Journal of Virus Eradication
|
September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
Joseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
Page
of 7